Director, Business Development & Transactions

• Drive Transformational Growth: Lead high-value transactions that bring forward new therapies, technologies, and scientific innovations—directly shaping the Institute’s long-term trajectory.
• Shape Strategic Direction: Partner closely with founders and senior executives to inform, refine, and advance enterprise-level strategy in a high-trust, highly collaborative environment.
• Visibility That Accelerates Impact: Operate in a role where your decisions influence scientific, operational, and organizational outcomes—and where your expertise is recognized at the highest levels.
• Autonomy With Purpose: Enjoy the latitude of a start-up environment combined with the mission-centered focus of a world-class research institute committed to improving patient lives.

• Lead structuring, negotiation, and execution of term sheets and definitive agreements for in-licensing, out-licensing, co-development, and strategic collaborations.
• Develop creative deal architectures, including options-to-license, regional rights, risk-sharing structures, and co-development models.
• Negotiate and finalize collaboration agreements with academic institutions, research hospitals, technology developers, and data platform partners.
• Drive internal alignment across scientific, clinical, finance, and legal functions.
• Present opportunities and recommendations to senior leadership and ensure seamless transition to alliance management post-deal.

• Identify and evaluate external technologies, discovery platforms, and therapeutic assets aligned with Institute priorities.
• Assess internal programs for partnering or out-licensing opportunities as they progress toward clinical development.
• Lead and coordinate cross-functional due diligence, including scientific, clinical, regulatory, IP, and financial assessments.
• Analyze market opportunities, scenarios, risks, and projected value creation.

• Integrate market intelligence, competitive landscape insights, and deal trend analyses to guide strategic decision-making.
• Develop valuation models and financial forecasts to support business cases.
• Contribute to long-range portfolio and partnership strategy with executive leadership.

• Represent the Institute at partnering conferences, investor events, and scientific meetings.
• Build and maintain productive relationships with biotech, pharma, venture, and academic partners.
• Cultivate a broad network enabling early access to emerging technologies and scientific innovation.

• Required Education:
  • Master’s or Ph.D. in a relevant scientific discipline (e.g., biology, chemistry, pharmacology, or related field).
  • MBA strongly preferred; must demonstrate strong grounding in strategy, finance, and valuation.
• Required Experience:
  • 10+ years of biotech/pharma experience in business development, licensing, or corporate development.
  • Proven track record leading and closing in-licensing, out-licensing, and co-development transactions spanning preclinical through Phase 1-2 development.
  • Experience in both large/mid-cap pharma or biotech and fast-paced start-up environments strongly preferred.
  • Comprehensive understanding of drug discovery, translational research, clinical development, and regulatory pathways.
  • High scientific fluency with the ability to partner effectively with discovery, translational, and clinical leaders.
  • Advanced proficiency in financial modeling, valuation, deal structuring, and strategic analysis.
• Required Skills:
  • Strategic, entrepreneurial mindset with disciplined execution.
  • Ability to integrate scientific, clinical, commercial, and financial perspectives into sound business decision-making.
  • Strong deal leadership—able to independently drive transactions from sourcing through signed agreement.
  • Exceptional communication skills with executive presence and the ability to influence across functions and levels.
  • Motivated by building partnerships that advance science and deliver meaningful patient impact.

Powered by JazzHR